{"id":"https://openalex.org/W7216520105","doi":"https://doi.org/10.70082/qezx1j11","title":"Immunotherapy Outcomes In Colorectal Cancer: A Systematic Review","display_name":"Immunotherapy Outcomes In Colorectal Cancer: A Systematic Review","publication_year":2025,"publication_date":"2025-09-14","ids":{"openalex":"https://openalex.org/W7216520105","doi":"https://doi.org/10.70082/qezx1j11"},"language":"en","primary_location":{"id":"pmh:oai:diabeticstudies.org:article/1896","doi":"https://doi.org/10.70082/qezx1j11","is_oa":true,"landing_page_url":"https://diabeticstudies.org/index.php/RDS/article/view/1896","pdf_url":"https://diabeticstudies.org/index.php/RDS/article/download/1896/1698","source":{"id":"https://openalex.org/S4210225960","display_name":"The Review of Diabetic Studies","issn_l":"1613-6071","issn":["1613-6071","1613-0575","1614-0575"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/I4210111253","host_organization_name":"Society for Biomedical Diabetes Research","host_organization_lineage":["https://openalex.org/I4210111253"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1613-6071","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://diabeticstudies.org/index.php/RDS/article/download/1896/1698","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5154738612","display_name":"Dr. Abeer kamal Habash","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1335369389","display_name":"Riyadh Armed Forces Hospital","ror":"https://ror.org/00mtny680","country_code":"SA","type":"healthcare","lineage":["https://openalex.org/I1335369389"]}],"countries":["SA"],"is_corresponding":false,"raw_author_name":"Habash, Dr. Abeer kamal","raw_affiliation_strings":["Medical Oncologist , Prince Sultan Military Medical City , Riyadh , Saudi Arabia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncologist , Prince Sultan Military Medical City , Riyadh , Saudi Arabia","institution_ids":["https://openalex.org/I1335369389"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5114073186","display_name":"Omar Alshaer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210088414","display_name":"CancerCare Manitoba","ror":"https://ror.org/005cmms77","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I4210088414"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Alshaer, Dr. Omar","raw_affiliation_strings":["Medical Oncologist , Cancercare Manitoba Winnipeg , Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncologist , Cancercare Manitoba Winnipeg , Canada","institution_ids":["https://openalex.org/I4210088414"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.8256999850273132,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11067","display_name":"Colorectal Cancer Treatments and Studies","score":0.15770000219345093,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11369","display_name":"Genetic factors in colorectal cancer","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.7789999842643738},{"id":"https://openalex.org/keywords/colorectal-cancer","display_name":"colorectal cancer","score":0.9769999980926514},{"id":"https://openalex.org/keywords/microsatellite-instability-high","display_name":"microsatellite instability-high","score":0.8149999976158142},{"id":"https://openalex.org/keywords/microsatellite-stability","display_name":"microsatellite stable","score":0.7310000061988831},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.878000020980835},{"id":"https://openalex.org/keywords/pembrolizumab","display_name":"pembrolizumab","score":0.9129999876022339},{"id":"https://openalex.org/keywords/nivolumab","display_name":"nivolumab","score":0.8870000243186951},{"id":"https://openalex.org/keywords/relatlimab","display_name":"relatlimab","score":0.8970000147819519},{"id":"https://openalex.org/keywords/neoadjuvant-immunotherapy","display_name":"neoadjuvant immunotherapy","score":0.9900000095367432},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9269999861717224},{"id":"https://openalex.org/keywords/metastatic-colorectal-cancer","display_name":"metastatic colorectal cancer","score":0.8519999980926514},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5830000042915344},{"id":"https://openalex.org/keywords/biomarker-driven-patient-selection","display_name":"biomarker-driven patient selection","score":0.8349999785423279}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8973000049591064},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.7208999991416931},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.679099977016449},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6420000195503235},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.5260000228881836},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.49639999866485596},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4846999943256378},{"id":"https://openalex.org/C2779767149","wikidata":"https://www.wikidata.org/wiki/Q488212","display_name":"Microsatellite instability","level":5,"score":0.41190001368522644},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.4106000065803528},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.3889999985694885},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.37940001487731934},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.35120001435279846},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.34540000557899475},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.31360000371932983},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3075999915599823},{"id":"https://openalex.org/C189708586","wikidata":"https://www.wikidata.org/wiki/Q1504425","display_name":"Systematic review","level":3,"score":0.3050000071525574},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.2971000075340271},{"id":"https://openalex.org/C10515644","wikidata":"https://www.wikidata.org/wiki/Q543310","display_name":"Survival analysis","level":2,"score":0.2888999879360199},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.2865999937057495},{"id":"https://openalex.org/C2776283816","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Survival rate","level":2,"score":0.27900001406669617},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.27900001406669617},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.27900001406669617},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2540999948978424}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:diabeticstudies.org:article/1896","doi":"https://doi.org/10.70082/qezx1j11","is_oa":true,"landing_page_url":"https://diabeticstudies.org/index.php/RDS/article/view/1896","pdf_url":"https://diabeticstudies.org/index.php/RDS/article/download/1896/1698","source":{"id":"https://openalex.org/S4210225960","display_name":"The Review of Diabetic Studies","issn_l":"1613-6071","issn":["1613-6071","1613-0575","1614-0575"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/I4210111253","host_organization_name":"Society for Biomedical Diabetes Research","host_organization_lineage":["https://openalex.org/I4210111253"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1613-6071","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:diabeticstudies.org:article/1896","doi":"https://doi.org/10.70082/qezx1j11","is_oa":true,"landing_page_url":"https://diabeticstudies.org/index.php/RDS/article/view/1896","pdf_url":"https://diabeticstudies.org/index.php/RDS/article/download/1896/1698","source":{"id":"https://openalex.org/S4210225960","display_name":"The Review of Diabetic Studies","issn_l":"1613-6071","issn":["1613-6071","1613-0575","1614-0575"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","jufo-1","ki-jl-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/I4210111253","host_organization_name":"Society for Biomedical Diabetes Research","host_organization_lineage":["https://openalex.org/I4210111253"],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"1613-6071","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Systematic Review","id":"https://openalex.org/study-designs/systematic-review"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7216520105.pdf","grobid_xml":"https://content.openalex.org/works/W7216520105.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7212176187","https://openalex.org/W7203477373","https://openalex.org/W4416982925","https://openalex.org/W7159768913","https://openalex.org/W3096342452","https://openalex.org/W4400344723","https://openalex.org/W4410821471","https://openalex.org/W7162761947","https://openalex.org/W4416214167","https://openalex.org/W2946276219"],"abstract_inverted_index":{"Background:":[0],"Immunotherapy":[1,244],"has":[2],"shown":[3],"transformative":[4],"efficacy":[5,141,293],"in":[6,59,84,159,241,277,294],"mismatch":[7,33],"repair-deficient":[8],"(dMMR)":[9],"or":[10,32,260],"microsatellite":[11],"instability-high":[12],"(MSI-H)":[13],"subtypes":[14],"of":[15,40,91,134,204,238,255,311],"colorectal":[16],"cancer":[17],"(CRC),":[18],"which":[19],"is":[20,57],"a":[21,72,234],"major":[22],"global":[23],"health":[24],"burden.":[25],"However,":[26],"most":[27],"patients":[28,256],"have":[29],"microsatellite-stable":[30],"(MSS)":[31],"repair-proficient":[34],"(pMMR)":[35],"disease,":[36],"where":[37],"the":[38,112,117,132,160,221,298,309],"benefits":[39,310],"immunotherapy":[41,48,209,272],"are":[42],"still":[43],"limited.":[44],"Current":[45],"data":[46,161],"on":[47],"results":[49],"across":[50,280],"various":[51],"CRC":[52,170,279],"populations":[53,225,296],"and":[54,82,89,105,123,153,187,283,288,303],"treatment":[55,281],"settings":[56],"compiled":[58],"this":[60],"systematic":[61,73],"review.":[62],"Methods:":[63],"In":[64,202],"accordance":[65],"with":[66,178,233,251,269,285],"PRISMA":[67],"standards,":[68],"we":[69],"carried":[70],"out":[71],"review":[74],"by":[75],"searching":[76],"for":[77,121,125,300],"articles":[78],"published":[79],"between":[80],"2000":[81],"2025":[83],"Cochrane":[85],"CENTRAL,":[86],"PubMed":[87],"Central,":[88],"Web":[90],"Science.":[92],"Two":[93],"Phase":[94,101],"III":[95],"randomized":[96],"controlled":[97],"trials":[98],"(RCTs),":[99],"five":[100],"II":[102],"single-arm":[103],"trials,":[104],"one":[106],"retrospective":[107],"cohort":[108,126],"study":[109],"were":[110,128,156],"among":[111],"eight":[113],"studies":[114,127],"that":[115],"satisfied":[116],"inclusion":[118],"criteria.":[119],"ROB-2":[120],"RCTs":[122],"ROBINS-I":[124],"used":[129],"to":[130,174,185,196,218,253,267,307],"evaluate":[131],"risk":[133],"bias.":[135],"Study":[136],"design,":[137],"sample":[138],"characteristics,":[139],"interventions,":[140],"outcomes":[142,228],"(overall":[143],"survival,":[144,146],"progression-free":[145,189],"objective":[147,179],"response":[148,180,213],"rate,":[149],"disease":[150],"control":[151],"rate),":[152],"safety":[154,247,287],"profiles":[155],"all":[157],"included":[158],"extraction":[162],"process.":[163],"Results:":[164],"Among":[165],"1,371":[166],"patients,":[167],"MSI-H/dMMR":[168,278],"metastatic":[169],"showed":[171,210],"strong":[172],"responses":[173],"immune":[175],"checkpoint":[176],"inhibitors,":[177],"rates":[181,214],"ranging":[182,191,215],"from":[183,192,216],"43.8%":[184],"50%":[186],"median":[188,235],"survival":[190,237],"16.5":[193],"months":[194,240],"(pembrolizumab)":[195],"not":[197],"reached":[198],"(nivolumab":[199],"plus":[200],"relatlimab).":[201],"cases":[203],"localized":[205],"dMMR":[206],"illness,":[207],"neoadjuvant":[208],"pathologic":[211],"complete":[212],"44%":[217],"68%.":[219],"On":[220],"other":[222],"hand,":[223],"MSS":[224,295],"had":[226,245],"worse":[227],"than":[229,249],"normal":[230],"salvage":[231],"therapy":[232],"overall":[236],"10.9":[239],"refractory":[242],"situations.":[243],"better":[246],"ratings":[248],"chemotherapy,":[250],"10%":[252],"23%":[254],"experiencing":[257],"grade":[258],"3":[259],"greater":[261],"treatment-related":[262],"side":[263],"events":[264],"versus":[265],"48%":[266],"66%":[268],"chemotherapy.":[270],"Conclusion:":[271],"provides":[273],"significant":[274],"therapeutic":[275],"benefit":[276],"lines":[282],"contexts,":[284],"positive":[286],"long-lasting":[289],"responses.":[290],"The":[291],"low":[292],"highlights":[297],"necessity":[299],"combined":[301],"techniques":[302],"biomarker-driven":[304],"patient":[305],"selection":[306],"increase":[308],"immunotherapy.":[312]},"counts_by_year":[],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2026-10-03T00:00:00"}